FNFDCM
ABBV icon

Folger Nolan Fleming Douglas Capital Management’s AbbVie ABBV Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
13,924
+57
+0.4% +$12.3K 0.29% 64
2026
Q1 		$3.02M Sell
13,867
-25
-0.2% -$5.55K 0.27% 63
2025
Q4 		$3.17M Sell
13,892
-54
-0.4% -$12.3K 0.33% 56
2025
Q3 		$3.23M Buy
13,946
+45
+0.3% +$9.16K 0.34% 55
2025
Q2 		$2.58M Sell
13,901
-214
-2% -$39.8K 0.29% 57
2025
Q1 		$2.96M Sell
14,115
-95
-0.7% -$18.5K 0.33% 55
2024
Q4 		$2.53M Sell
14,210
-415
-3% -$76.3K 0.26% 57
2024
Q3 		$2.89M Sell
14,625
-227
-2% -$42.4K 0.29% 53
2024
Q2 		$2.55M Sell
14,852
-3,226
-18% -$534K 0.26% 54
2024
Q1 		$3.29M Sell
18,078
-38
-0.2% -$6.55K 0.34% 50
2023
Q4 		$2.81M Sell
18,116
-135
-0.7% -$19.7K 0.31% 51
2023
Q3 		$2.72M Sell
18,251
-737
-4% -$108K 0.32% 51
2023
Q2 		$2.56M Sell
18,988
-622
-3% -$91.2K 0.28% 56
2023
Q1 		$3.13M Sell
19,610
-1,765
-8% -$270K 0.36% 48
2022
Q4 		$3.45M Buy
21,375
+3,153
+17% +$483K 0.41% 48
2022
Q3 		$2.45M Buy
18,222
+606
+3% +$87K 0.33% 54
2022
Q2 		$2.7M Buy
17,616
+1
+0% +$153 0.35% 52
2022
Q1 		$2.86M Buy
17,615
+67
+0.4% +$9.73K 0.32% 53
2021
Q4 		$2.38M Buy
17,548
+576
+3% +$68K 0.26% 60
2021
Q3 		$1.83M Sell
16,972
-360
-2% -$41.1K 0.22% 64
2021
Q2 		$1.95M Sell
17,332
-345
-2% -$38.9K 0.23% 63
2021
Q1 		$1.91M Hold
17,677
– – 0.23% 62
2020
Q4 		$1.89M Buy
17,677
+100
+0.6% +$9.61K 0.25% 58
2020
Q3 		$1.54M Sell
17,577
-100
-0.6% -$9.41K 0.23% 61
2020
Q2 		$1.74M Sell
17,677
-274
-2% -$24.1K 0.28% 60
2020
Q1 		$1.37M Sell
17,951
-420
-2% -$35.8K 0.27% 64
2019
Q4 		$1.63M Sell
18,371
-155
-0.8% -$12.9K 0.24% 65
2019
Q3 		$1.4M Buy
18,526
+574
+3% +$39.4K 0.22% 67
2019
Q2 		$1.3M Sell
17,952
-350
-2% -$27.5K 0.2% 68
2019
Q1 		$1.48M Sell
18,302
-200
-1% -$16.4K 0.22% 64
2018
Q4 		$1.71M Sell
18,502
-225
-1% -$19.8K 0.28% 61
2018
Q3 		$1.77M Sell
18,727
-1,160
-6% -$110K 0.25% 61
2018
Q2 		$1.84M Sell
19,887
-1,050
-5% -$103K 0.27% 61
2018
Q1 		$1.98M Sell
20,937
-650
-3% -$71.4K 0.3% 59
2017
Q4 		$2.09M Sell
21,587
-3,560
-14% -$336K 0.29% 59
2017
Q3 		$2.23M Sell
25,147
-50
-0.2% -$3.81K 0.32% 56
2017
Q2 		$1.83M Sell
25,197
-284
-1% -$19.1K 0.28% 61
2017
Q1 		$1.66M Sell
25,481
-1,206
-5% -$75.8K 0.25% 62
2016
Q4 		$1.77M Hold
26,687
– – 0.29% 61
2016
Q3 		$1.77M Hold
26,687
– – 0.29% 61
2016
Q2 		$1.65M Sell
26,687
-761
-3% -$46.4K 0.28% 63
2016
Q1 		$1.57M Buy
27,448
+555
+2% +$30.9K 0.28% 62
2015
Q4 		$1.59M Sell
26,893
-395
-1% -$22.8K 0.28% 62
2015
Q3 		$1.49M Sell
27,288
-1,204
-4% -$78.4K 0.3% 64
2015
Q2 		$1.91M Sell
28,492
-254
-0.9% -$16.6K 0.35% 59
2015
Q1 		$1.68M Sell
28,746
-250
-0.9% -$15.1K 0.29% 63
2014
Q4 		$1.9M Sell
28,996
-1,552
-5% -$97.8K 0.33% 58
2014
Q3 		$1.76M Sell
30,548
-2,354
-7% -$131K 0.32% 60
2014
Q2 		$1.86M Sell
32,902
-726
-2% -$38.1K 0.34% 60
2014
Q1 		$1.73M Sell
33,628
-15,177
-31% -$767K 0.36% 59
2013
Q4 		$2.58M Sell
48,805
-2,002
-4% -$98.4K 0.45% 43
2013
Q3 		$2.27M Sell
50,807
-4,095
-7% -$182K 0.44% 47
2013
Q2 		$2.27M Buy
+54,902
New +$2.4M 0.47% 44

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's ABBV Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management increased its AbbVie (ABBV) stake by 0.41% in Q2 2026, buying an estimated $12.3K and bringing the position to 13,924 shares worth $3.5M. The position accounts for 0.29% of the portfolio, ranked #64.

Folger Nolan Fleming Douglas Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,482 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 13,924 shares of AbbVie worth $3.5M as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management bought 57 AbbVie shares in Q2 2026, an estimated $12.3K.
  • AbbVie made up 0.29% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #64 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,482 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.